Oral corticosteroid dosage and clinical presentation of psychiatric conditions after steroid use: A consultation‐liaison psychiatry service’s experience-Reference-Cited by-同舟云学术

Oral corticosteroid dosage and clinical presentation of psychiatric conditions after steroid use: A consultation‐liaison psychiatry service’s experience

Published:2021-08-31 Issue:4 Volume:41 Page:471-475
ISSN:2574-173X
Container-title:Neuropsychopharmacology Reports
language:en
Short-container-title:Neuropsychopharm Rep

Author:

Yagi Yuko¹²^ORCID,Takahashi Yusuke¹³,Ogata Yu¹^ORCID,Yamana Hayato¹⁴,Kumakura Yousuke¹⁵,Ichihashi Kayo¹,Kasai Kiyoto¹,Kondo Shinsuke¹^ORCID

Affiliation:

1. Department of Neuropsychiatry The University of Tokyo Hospital Bunkyo‐ku Japan

2. Japanese Red Cross Medical Center Shibuya‐ku Japan

3. St. Luke’s International Hospital Chuo‐ku Japan

4. Department of Health Services Research Graduate School of Medicine The University of Tokyo Bunkyo‐ku Japan

5. Department of Mental Health Graduate School of Medicine The University of Tokyo Bunkyo‐ku Japan

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Clinical Psychology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/npr2.12204

Reference21 articles.

1. Systemic Adverse Effects of Inhaled Corticosteroid Therapy

2. Sleep, the hypothalamic–pituitary–adrenal axis, and cytokines: multiple interactions and disturbances in sleep disorders

3. Mood and Cognitive Changes During Systemic Corticosteroid Therapy

4. Suicidal Behavior and Severe Neuropsychiatric Disorders Following Glucocorticoid Therapy in Primary Care

5. Steroid-induced psychiatric disorders

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association Between Prolonged Use of Oral Corticosteroids and Mental Disorders: Do Steroids Have a Role in Developing Mental Disorders?;Cureus;2023-04-15

2. Long‐term effects of glucocorticoid excess on the brain;Journal of Neuroendocrinology;2022-08

3. Prednisolone;Reactions Weekly;2022-06

4. Neuropsychiatric Adverse Effects of Immunosuppressant Agents;Transplant Psychiatry;2022